Search Results Search Sort by RelevanceMost Recent Letter to the Editor Jul 2020 Response to “How Should Global Tobacco Control Efforts Be Prioritized to Protect Children in Resource-Poor Regions?” A Deliberate Public Policy Plus Naivety at Best Alain Braillon, MD, PhD Do the WHO and health professionals simply fail to do their job adequately? AMA J Ethics. 2020;22(7):E639-642. doi: 10.1001/amajethics.2020.639. Letter to the Editor Jul 2020 Response to “A Deliberate Public Policy Plus Naivety at Best” Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD Debate continues on how to frame tobacco and nicotine product regulation from a children’s rights perspective. AMA J Ethics. 2020;22(7):E643-644. doi: 10.1001/amajethics.2020.643. Medical Education Aug 2020 What Clinicians and Health Professions Students Should Learn About How Pharmaceutical Marketing Influences Opioid Prescribing and Patient Outcomes Michael A. Erdek, MD, MA Key policy changes would better situate clinicians to prescribe care in ways that are ethical, safe, and effective. AMA J Ethics. 2020;22(8):E681-686. doi: 10.1001/amajethics.2020.681. State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687. Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702. Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723. Policy Forum Feb 2022 Por qué los enfoques no carcelarios basados en la atención para las personas detenidas con enfermedades mentales son clave para volver a confiar o no en los profesionales o la autoridad estatal Frederic G. Reamer, PhD AMA J Ethics. 2022;E145-149. doi: 10.1001/amajethics.2022.145. Health Law May 2022 Does Regulating Dietary Supplements as Food in a World of Social Media Influencers Promote Public Safety? Joshua J. Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences. AMA J Ethics. 2022;24(5):E396-401. doi: 10.1001/amajethics.2022.396. Case and Commentary Jun 2022 How Should Health Systems Help Clinicians Manage Bias Against Ex-combatants? Christopher W. Reynolds and Camilo Sánchez Meertens, MPP Clinicians in postconflict health care settings can be tasked with caring for patients who were enemies. AMA J Ethics. 2022;24(6):E483-488. doi: 10.1001/amajethics.2022.483. Health Law Jun 2022 Survivor-Centered Approaches to Conflict-Related Sexual Violence in International Humanitarian and Human Rights Law Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil During or after conflict, a clinician might be required to provide evidence to an official investigatory body or court. AMA J Ethics. 2022;24(6):E495-517. doi: 10.1001/amajethics.2022.495. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last »
Letter to the Editor Jul 2020 Response to “How Should Global Tobacco Control Efforts Be Prioritized to Protect Children in Resource-Poor Regions?” A Deliberate Public Policy Plus Naivety at Best Alain Braillon, MD, PhD Do the WHO and health professionals simply fail to do their job adequately? AMA J Ethics. 2020;22(7):E639-642. doi: 10.1001/amajethics.2020.639.
Letter to the Editor Jul 2020 Response to “A Deliberate Public Policy Plus Naivety at Best” Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD Debate continues on how to frame tobacco and nicotine product regulation from a children’s rights perspective. AMA J Ethics. 2020;22(7):E643-644. doi: 10.1001/amajethics.2020.643.
Medical Education Aug 2020 What Clinicians and Health Professions Students Should Learn About How Pharmaceutical Marketing Influences Opioid Prescribing and Patient Outcomes Michael A. Erdek, MD, MA Key policy changes would better situate clinicians to prescribe care in ways that are ethical, safe, and effective. AMA J Ethics. 2020;22(8):E681-686. doi: 10.1001/amajethics.2020.681.
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702.
Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723.
Policy Forum Feb 2022 Por qué los enfoques no carcelarios basados en la atención para las personas detenidas con enfermedades mentales son clave para volver a confiar o no en los profesionales o la autoridad estatal Frederic G. Reamer, PhD AMA J Ethics. 2022;E145-149. doi: 10.1001/amajethics.2022.145.
Health Law May 2022 Does Regulating Dietary Supplements as Food in a World of Social Media Influencers Promote Public Safety? Joshua J. Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences. AMA J Ethics. 2022;24(5):E396-401. doi: 10.1001/amajethics.2022.396.
Case and Commentary Jun 2022 How Should Health Systems Help Clinicians Manage Bias Against Ex-combatants? Christopher W. Reynolds and Camilo Sánchez Meertens, MPP Clinicians in postconflict health care settings can be tasked with caring for patients who were enemies. AMA J Ethics. 2022;24(6):E483-488. doi: 10.1001/amajethics.2022.483.
Health Law Jun 2022 Survivor-Centered Approaches to Conflict-Related Sexual Violence in International Humanitarian and Human Rights Law Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil During or after conflict, a clinician might be required to provide evidence to an official investigatory body or court. AMA J Ethics. 2022;24(6):E495-517. doi: 10.1001/amajethics.2022.495.